May 2006
Volume 47, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2006
Conventional and Wave Front Guided EpiLASIK With a 500 Hz Excimer Laser System for the Correction of Myopia: 6 Months Results
Author Affiliations & Notes
  • K. Hufendiek
    Ophthalmology, University, Regensburg, Germany
  • W.A. Herrmann
    Ophthalmology, University, Regensburg, Germany
  • P. Prahs
    Ophthalmology, University, Regensburg, Germany
  • V.P. Gabel
    Ophthalmology, University, Regensburg, Germany
  • Footnotes
    Commercial Relationships  K. Hufendiek, None; W.A. Herrmann, None; P. Prahs, None; V.P. Gabel, None.
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science May 2006, Vol.47, 521. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      K. Hufendiek, W.A. Herrmann, P. Prahs, V.P. Gabel; Conventional and Wave Front Guided EpiLASIK With a 500 Hz Excimer Laser System for the Correction of Myopia: 6 Months Results . Invest. Ophthalmol. Vis. Sci. 2006;47(13):521.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To evaluate the safety and efficacy of conventional and wave front guided (WFG) EpiLASIK with a 500 Hz Excimer Laser System.

Methods: : 278 consecutive eyes of 201 patients (mean age 35,3±17,4 years) with mild to moderate myopia (mean SE –4,27 D ± 2,61 D) that underwent conventional (conv.) EpiLASIK and 58 consecutive eyes of 44 patients (mean age 33±23,3 years) with myopia (mean SE –3,54 D ± 1,97 D) that underwent wave front guided (WFG) EpiLASIK were included in the study. An epithelial flap with a nasal hinge was generated using an EpiLASIK Keratome (EpiTome, Gebauer, Germany). Photoablation was performed with a Wavelight Concept 500 Excimer Laser (Wavelight, Erlangen, Germany). After photoablation the epithelial flap was repositioned and secured with a soft bandage contact lens (Pure Vision, Bausch & Lomb). 3 days after surgery the contact lens was removed. Postoperative outcomes included uncorrected visual acuity (UCVA), best spectacle–corrected visual acuity (BSCVA), and spherical equivalent refractions (SE).

Results: : At 4 weeks, 41,5% achieved 20/20 or better UCVA after conv. EpiLASIK, and 66,0% achieved 20/20 or better UCVA after WFG EpiLASIK, while 95,3% achieved 20/40 or better UCVA after conv. EpiLASIK and 94,0% achieved 20/40 or better in the WFG group. SE was –0,01D±0,86D and 0,07D±0,64D, respectively. 70,9% achieved 20/20 or better BSCVA and 97,8% achieved 20/40 or better BSCVA after conventional EpiLASIK, while 86,7% achieved 20/20 or better BSCVA and 100,0% achieved 20/40 or better BSCVA after WFG EpiLASIK. At 3 months, 61,0% achieved 20/20 or better UCVA after conv. EpiLASIK and 67,2% achieved 20/20 or better UCVA after WFG EpiLASIK. 97,9% achieved 20/40 or better UCVA after conv. EpiLASIK and 100,0% achieved 20/40 or better in the WFG group. SE was 0,00D±0,56D and –0,03D±0,56D, respectively. 82,8% achieved 20/20 or better BSCVA and 100,0% achieved 20/40 or better BSCVA after conv. EpiLASIK, while 100,0% achieved 20/20 or better BSCVA after WFG EpiLASIK. At 6 months, 65,6% achieved 20/20 or better UCVA after conv. EpiLASIK and 70,0% achieved 20/20 or better UCVA after WFG EpiLASIK, while 98,8% achieved 20/40 or better UCVA after conv. EpiLASIK and 100,0% achieved 20/40 or better in the WFG group. SE was 0,11D±0,69D and 0,13D±0,41D, respectively. 85,0% achieved 20/20 or better BSCVA and 100,0% achieved 20/40 or better BSCVA after conv. EpiLASIK, while 100,0% achieved 20/20 or better BSCVA after WFG EpiLASIK.

Conclusions: : Both conventional and wave front guided EpiLASIK are safe and effective procedures for the correction of mild to moderate myopia.

Keywords: cornea: epithelium • refractive surgery: other technologies • refractive surgery: optical quality 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×